Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Cancer letters [Cancer Lett] NLMUID: 7600053"" wg kryterium: JN


Tytuł :
Targeting ubiquitin conjugating enzyme UbcH5b by a triterpenoid PC3-15 from Schisandra plants sensitizes triple-negative breast cancer cells to lapatinib.
Autorzy :
Huang M; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China; Kunming College of Life Sciences, University of Chinese Academy Sciences, Kunming, Yunnan, China.
Zhou Y; Kunming College of Life Sciences, University of Chinese Academy Sciences, Kunming, Yunnan, China; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, Yunnan, China.
Duan D; Shaanxi Key Laboratory of Phytochemistry and College of Chemistry and Chemical Engineering, Baoji University of Arts and Sciences, Baoji, 721013, China.
Yang C; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China.
Zhou Z; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China.
Li F; Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, 510095, China.
Kong Y; Biobank, Shenzhen Second People's Hospital/ the First Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, 518035, China.
Hsieh YC; The Center for Cell Biology and Cancer Research, Albany Medical College, 47 New Scotland Ave, Albany, NY, 12208, USA.
Zhang R; Key Laboratory of Medicinal Chemistry for Key Laboratory of Medicinal Chemistry for Natural Resource (Ministry of Education and Yunnan Province), State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, School of Chemical Science and Technology, Yunnan University, 2 North Cuihu Road, Kunming, 650091, China.
Ding W; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, Yunnan, China.
Xiao W; Key Laboratory of Medicinal Chemistry for Key Laboratory of Medicinal Chemistry for Natural Resource (Ministry of Education and Yunnan Province), State Key Laboratory for Conservation and Utilization of Bio-Resources in Yunnan, School of Chemical Science and Technology, Yunnan University, 2 North Cuihu Road, Kunming, 650091, China.
Puno P; State Key Laboratory of Phytochemistry and Plant Resources in West China, Kunming Institute of Botany, Chinese Academy of Sciences, Kunming, 650201, Yunnan, China. Electronic address: .
Chen C; Key Laboratory of Animal Models and Human Disease Mechanisms of Chinese Academy of Sciences & Yunnan Province, Kunming Institute of Zoology, Kunming, Yunnan, China; KIZ-CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, 650223, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 125-136. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
OTUD5-mediated deubiquitination of YAP in macrophage promotes M2 phenotype polarization and favors triple-negative breast cancer progression.
Autorzy :
Zhang Y; Department of Respiratory and Critical Care Medicine, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Fan Y; Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address: .
Jing X; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhao L; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Liu T; Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Wang L; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Zhang L; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
Gu S; Department of Forensic Medicine, Medical School of Xi'an Jiaotong University, Xi'an, China. Electronic address: .
Zhao X; Department of Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address: .
Teng Y; Department of Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 104-115. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Noncoding RNAs in osteosarcoma: Implications for drug resistance.
Autorzy :
Lin Z; Department of Orthopedics, The Second Xiangya Hospital of Central South University, 139 Renmin Road, Changsha, 410011, Hunan, People's Republic of China; Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan Province, China. Electronic address: .
Xie X; Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan Province, China. Electronic address: .
Lu S; Xiangya School of Medicine, Central South University, Changsha, 410013, Hunan Province, China. Electronic address: .
Liu T; Department of Orthopedics, The Second Xiangya Hospital of Central South University, 139 Renmin Road, Changsha, 410011, Hunan, People's Republic of China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 91-103. Date of Electronic Publication: 2021 Feb 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Parallel genome-wide RNAi screens identify lymphocyte-specific protein tyrosine kinase (LCK) as a targetable vulnerability of cell proliferation and chemoresistance in nasopharyngeal carcinoma.
Autorzy :
Liew K; Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
Yu GQS; School of Medicine, International Medical University, Kuala Lumpur, Malaysia.
Wei Pua LJ; Center for Cancer and Stem Cell Research, Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
Wong LZ; Center for Cancer and Stem Cell Research, Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
Tham SY; Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
Hii LW; Center for Cancer and Stem Cell Research, Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
Lim WM; Center for Cancer and Stem Cell Research, Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
OuYong BM; School of Medicine, International Medical University, Kuala Lumpur, Malaysia.
Looi CK; Center for Cancer and Stem Cell Research, Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
Mai CW; Center for Cancer and Stem Cell Research, Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia; State Key Laboratory of Oncogenes and Related Genes, Renji-Med X Clinical Stem Cell Research Center, Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200127, China.
Fei-Lei Chung F; Mechanisms of Carcinogenesis Section (MCA), Epigenetics Group (EGE), International Agency for Research on Cancer World Health Organization, Lyon CEDEX 08, France.
Tan LP; Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
Ahmad M; Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
Soo-Beng Khoo A; Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia; Center for Cancer and Stem Cell Research, Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia. Electronic address: .
Leong CO; Center for Cancer and Stem Cell Research, Institute for Research, Development and Innovation (IRDI), International Medical University, Kuala Lumpur, Malaysia; School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 81-90. Date of Electronic Publication: 2021 Feb 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Non-matrigel scaffolds for organoid cultures.
Autorzy :
Kaur S; Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India. Electronic address: .
Kaur I; Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
Rawal P; Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India; School of Biotechnology, Gautam Buddha University, Greater Noida, UP, India.
Tripathi DM; Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
Vasudevan A; Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 58-66. Date of Electronic Publication: 2021 Feb 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Emerging biofabrication approaches for gastrointestinal organoids towards patient specific cancer models.
Autorzy :
Soto F; Canary Center at Stanford for Cancer Early Detection, Bio-Acoustic MEMS in Medicine (BAMM) Laboratory, Department of Radiology, School of Medicine Stanford University, Palo Alto, California, 94304-5427, USA.
Guimarães CF; Canary Center at Stanford for Cancer Early Detection, Bio-Acoustic MEMS in Medicine (BAMM) Laboratory, Department of Radiology, School of Medicine Stanford University, Palo Alto, California, 94304-5427, USA; 3B's Research Group, Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal; ICVS/3B's, PT Government Associate Laboratory, University of Minho, Braga/Guimarães, Portugal.
Reis RL; 3B's Research Group, Research Institute on Biomaterials, Biodegradables and Biomimetics, University of Minho, Headquarters of the European Institute of Excellence on Tissue Engineering and Regenerative Medicine, AvePark, Parque de Ciência e Tecnologia, Zona Industrial da Gandra, 4805-017 Barco, Guimarães, Portugal; ICVS/3B's, PT Government Associate Laboratory, University of Minho, Braga/Guimarães, Portugal.
Franco W; Department of Biomedical Engineering, University of Massachusetts, Lowell, 01854, MA, USA; Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, 02114, MA, USA.
Rizvi I; Joint Department of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel Hill, NC and North Carolina State University, Raleigh, NC, 27599, USA; Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, NC, 27599, USA.
Demirci U; Canary Center at Stanford for Cancer Early Detection, Bio-Acoustic MEMS in Medicine (BAMM) Laboratory, Department of Radiology, School of Medicine Stanford University, Palo Alto, California, 94304-5427, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 116-124. Date of Electronic Publication: 2021 Feb 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Long non-coding RNAs in colorectal cancer: Novel oncogenic mechanisms and promising clinical applications.
Autorzy :
Yang Y; Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Yan X; Department of Oncology, Affiliated Hospital of Yangzhou University, Yangzhou, China.
Li X; Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: .
Ma Y; Department of Colorectal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: .
Goel A; Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, CA, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 67-80. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
TORC1/2 kinase inhibition depletes glutathione and synergizes with carboplatin to suppress the growth of MYC-driven medulloblastoma.
Autorzy :
Maynard RE; Division of Pediatric Oncology, Department of Oncology, USA.
Poore B; Division of Pediatric Oncology, Department of Oncology, USA; Pathobiology Graduate Program, USA.
Hanaford AR; Division of Pediatric Oncology, Department of Oncology, USA; Pathobiology Graduate Program, USA.
Pham K; Division of Neuropathology, Department of Pathology, USA.
James M; Pathobiology Graduate Program, USA.
Alt J; Johns Hopkins Drug Discovery, USA.
Park Y; Division of Pediatric Oncology, Department of Oncology, USA.
Slusher BS; Johns Hopkins Drug Discovery, USA; Department of Neurology, USA.
Tamayo P; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA; Center for Novel Therapeutics, University of California San Diego, La Jolla, CA, USA; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Mesirov J; Moores Cancer Center, University of California San Diego, La Jolla, CA, USA; Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Archer TC; Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Cambridge, MA, USA.
Pomeroy SL; Eli and Edythe L. Broad Institute of MIT and Harvard, Cambridge, MA, USA; Department of Neurology, Boston Children's Hospital, Harvard Medical School, Cambridge, MA, USA.
Eberhart CG; Division of Neuropathology, Department of Pathology, USA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, USA.
Raabe EH; Division of Pediatric Oncology, Department of Oncology, USA; Division of Neuropathology, Department of Pathology, USA; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 137-145. Date of Electronic Publication: 2021 Feb 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Long non-coding RNA regulating androgen receptor signaling in breast and prostate cancer.
Autorzy :
Kumar S; Department of Biochemistry, Drug Discovery and Therapeutic Laboratory, Central University of Punjab, Bathinda, 151401, India. Electronic address: .
Prajapati KS; Department of Biochemistry, Drug Discovery and Therapeutic Laboratory, Central University of Punjab, Bathinda, 151401, India.
Singh AK; Department of Biochemistry, Drug Discovery and Therapeutic Laboratory, Central University of Punjab, Bathinda, 151401, India.
Kushwaha PP; Department of Biochemistry, Drug Discovery and Therapeutic Laboratory, Central University of Punjab, Bathinda, 151401, India.
Shuaib M; Department of Biochemistry, Drug Discovery and Therapeutic Laboratory, Central University of Punjab, Bathinda, 151401, India.
Gupta S; Department of Urology, Case Western Reserve University, Cleveland, OH, 44106, USA; The Urology Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, 44106, USA; Department of Nutrition, Case Western Reserve University, Cleveland, OH, 44106, USA; Division of General Medical Sciences, Case Comprehensive Cancer Center, Cleveland, OH, 44106, USA; Department of Urology, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, 44106, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 15-22. Date of Electronic Publication: 2021 Feb 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
DIM-C-pPhtBu induces lysosomal dysfunction and unfolded protein response - mediated cell death via excessive mitophagy.
Autorzy :
Kang SU; Department of Otolaryngology, Ajou University School of Medicine, Suwon, South Korea.
Kim DH; Department of Molecular Science & Technology, Ajou University, Suwon, South Korea.
Lee YS; Department of Otolaryngology, Ajou University School of Medicine, Suwon, South Korea.
Huang M; Department of Otolaryngology, Ajou University School of Medicine, Suwon, South Korea.
Byeon HK; Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Seoul, South Korea.
Lee SH; Department of Nutrition and Food Science, College of Agriculture and Natural Resources, University of Maryland, USA.
Baek SJ; College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul, South Korea.
Kim CH; Department of Otolaryngology, Ajou University School of Medicine, Suwon, South Korea; Department of Molecular Science & Technology, Ajou University, Suwon, South Korea. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 23-36. Date of Electronic Publication: 2021 Feb 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Trials and tribulations of pancreatic cancer immunotherapy.
Autorzy :
Principe DR; Medical Scientist Training Program, University of Illinois College of Medicine, Chicago, IL, USA; Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Chicago, IL, USA. Electronic address: .
Korc M; Department of Developmental and Cell Biology, University of California, Irvine, CA, USA.
Kamath SD; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
Munshi HG; Feinberg School of Medicine, Northwestern University, Chicago, IL, USA; Jesse Brown VA Medical Center, Chicago, IL, USA.
Rana A; Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Chicago, IL, USA; Jesse Brown VA Medical Center, Chicago, IL, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 1-14. Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Increased transcription and high translation efficiency lead to accumulation of androgen receptor splice variant after androgen deprivation therapy.
Autorzy :
Ma T; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.
Bai S; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.
Qi Y; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.
Zhan Y; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.
Ungerleider N; Department of Pathology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA.
Zhang DY; Lusher Charter School, New Orleans, LA, 70115, USA.
Neklesa T; Arvinas, New Haven, CT, USA.
Corey E; Department of Urology, University of Washington, Seattle, WA, USA.
Dehm SM; Department of Laboratory Medicine and Pathology and Department of Urology, University of Minnesota, Minneapolis, MN, USA.
Zhang K; Department of Computer Science, Bioinformatics Facility of Xavier RCMI Center of Cancer Research, Xavier University of Louisiana, New Orleans, LA, USA.
Flemington EK; Department of Pathology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA. Electronic address: .
Dong Y; Department of Structural and Cellular Biology, Tulane University School of Medicine, Tulane Cancer Center, New Orleans, LA, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 37-48. Date of Electronic Publication: 2021 Feb 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Depletion of androgen receptor low molecular weight isoform reduces bladder tumor cell viability and induces apoptosis.
Autorzy :
Katleba K; Veterans Affairs-Northern California Health Care System, Mather, CA, USA; Department of Medical Microbiology and Immunology, USA.
Lombard AP; Veterans Affairs-Northern California Health Care System, Mather, CA, USA; Department of Medical Microbiology and Immunology, USA; Biochemistry, Molecular, Cellular, and Developmental Biology Graduate Group and Biotechnology Program, USA.
Tsamouri MM; Veterans Affairs-Northern California Health Care System, Mather, CA, USA; Department of Urologic Surgery, University of California, 1 Shields Avenue, UC Davis, Davis, CA, 95616, USA.
Baek HB; Veterans Affairs-Northern California Health Care System, Mather, CA, USA; Department of Medical Microbiology and Immunology, USA.
Nishida KS; Department of Medical Microbiology and Immunology, USA.
Libertini SJ; Veterans Affairs-Northern California Health Care System, Mather, CA, USA; Department of Medical Microbiology and Immunology, USA.
Platero AJ; Department of Medical Microbiology and Immunology, USA.
Ma AH; Department of Urologic Surgery, University of California, 1 Shields Avenue, UC Davis, Davis, CA, 95616, USA.
Pan CX; Department of Faculty of Medicine, Harvard Medical School, West Roxbury, MA, 02115, USA.
Ghosh PM; Veterans Affairs-Northern California Health Care System, Mather, CA, USA; Department of Urologic Surgery, University of California, 1 Shields Avenue, UC Davis, Davis, CA, 95616, USA.
Mudryj M; Veterans Affairs-Northern California Health Care System, Mather, CA, USA; Department of Medical Microbiology and Immunology, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 28; Vol. 504, pp. 49-57. Date of Electronic Publication: 2021 Feb 04.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Targeting nutrient metabolism with FDA-approved drugs for cancer chemoprevention: Drugs and mechanisms.
Autorzy :
Xie Y; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China; Academy of Medical Sciences, Zhengzhou University, 40 North Daxue Road, Zhengzhou, Henan 450001, PR China.
Yao K; China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan 450008, PR China.
Dong Z; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China; Academy of Medical Sciences, Zhengzhou University, 40 North Daxue Road, Zhengzhou, Henan 450001, PR China; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou, Henan, China; China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan 450008, PR China; Henan Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou 450001, China. Electronic address: .
Liu K; Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, Zhengzhou 450001, China; Academy of Medical Sciences, Zhengzhou University, 40 North Daxue Road, Zhengzhou, Henan 450001, PR China; State Key Laboratory of Esophageal Cancer Prevention and Treatment, Zhengzhou, Henan, China; China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan 450008, PR China; Henan Provincial Cooperative Innovation Center for Cancer Chemoprevention, Zhengzhou 450001, China; Cancer Chemoprevention International Collaboration Laboratory, Zhengzhou, Henan, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 12. Date of Electronic Publication: 2021 Apr 12.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
LncRNA-miRNA axes in breast cancer: Novel points of interaction for strategic attack.
Autorzy :
Venkatesh J; Department of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada. Electronic address: .
Wasson MD; Department of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada. Electronic address: .
Brown JM; Department of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada. Electronic address: .
Fernando W; Department of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada. Electronic address: .
Marcato P; Department of Pathology, Dalhousie University, Halifax, NS B3H 4R2, Canada; Department of Microbiology & Immunology, Dalhousie University, Halifax, NS B3H 4R2, Canada. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 10. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
A minigene DNA vaccine encoding peptide epitopes derived from Galectin-1 has protective antitumoral effects in a model of neuroblastoma.
Autorzy :
Liebscher L; Department of Pediatric Oncology, Hematology and Hemostaseology, Medical Faculty, University of Leipzig, Leipzig, Germany.
Weißenborn C; Pediatric Immunotherapy Group, Medical Faculty, Otto-von Guericke University of Magdeburg, Germany; Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von Guericke University of Magdeburg, Germany.
Langwisch S; Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von Guericke University of Magdeburg, Germany.
Gohlke BO; Department of Information Technology, Science-IT, Charité - Universitätsmedizin Berlin, Germany.
Preissner R; Department of Information Technology, Science-IT, Charité - Universitätsmedizin Berlin, Germany.
Rabinovich GA; Laboratory of Immunopathology, Institute of Biology and Experimental Medicine (IBYME), National Research Council (CONICET), Buenos Aires, Argentina; Faculty of Exact and Natural Sciences, University of Buenos Aires, Buenos Aires, Argentina.
Christiansen N; Department of Pediatric Oncology, Hematology and Hemostaseology, Medical Faculty, University of Leipzig, Leipzig, Germany.
Christiansen H; Department of Pediatric Oncology, Hematology and Hemostaseology, Medical Faculty, University of Leipzig, Leipzig, Germany.
Zenclussen AC; Experimental Obstetrics and Gynecology, Medical Faculty, Otto-von Guericke University of Magdeburg, Germany; Department of Environmental Immunology, Helmholtz Centre for Environmental Research -UFZ, Leipzig, Germany.
Fest S; Pediatric Immunotherapy Group, Medical Faculty, Otto-von Guericke University of Magdeburg, Germany; Department of Environmental Immunology, Helmholtz Centre for Environmental Research -UFZ, Leipzig, Germany; Städtisches Klinikum Dessau, Academic Hospital of University Brandenburg, Dessau, Germany.
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 10. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Repression of the AURKA-CXCL5 axis induces autophagic cell death and promotes radiosensitivity in non-small-cell lung cancer.
Autorzy :
Wang J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Hu T; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Wang Q; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Chen R; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Xie Y; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Chang H; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Cheng J; Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 10. Date of Electronic Publication: 2021 Apr 10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis.
Autorzy :
Wang W; Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Wang Q; Department of Radiotherapy, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Department of Oncology, The Fifth Hospital of Wuhan, Wuhan, China; WuHan University, Wuhan, China.
Huang DB; Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Sun QK; Department of Hepatobiliary Surgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Wu SS; Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Zhao YJ; Department of Abdominal Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Jia W; Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China.
Hu DS; Department of Radiotherapy, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: .
He YF; Department of Medical Oncology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 10; Vol. 503, pp. 19-31. Date of Electronic Publication: 2021 Jan 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
In vivo selection of highly metastatic human ovarian cancer sublines reveals role for AMIGO2 in intra-peritoneal metastatic regulation.
Autorzy :
Liu Y; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, USA; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Yang J; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, USA; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Shi Z; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA; St. Jude Children's Research Hospital, Memphis, TN, USA.
Tan X; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA; Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA.
Jin N; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
O'Brien C; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Ott C; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Grisoli A; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Lee E; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Volk K; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Conroy M; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Franz E; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Bryant A; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Campbell L; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Crowley B; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Grisoli S; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Alexandrou AT; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA; Division of Oncology, Washington University School of Medicine, St. Louis, MO, USA.
Li C; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA; Department of Gynecology, Shandong Provincial Hospital, Shandong First Medical University, Jinan, China.
Harper EI; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, USA; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Asem M; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, USA; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Johnson J; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, USA; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Leonard A; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Santanello K; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Klein A; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Wang Q; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA; Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA.
Zhang S; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA; Department of Biological Sciences, University of Notre Dame, Notre Dame, IN, USA.
Hilliard TS; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, USA; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA.
Stack MS; Department of Chemistry & Biochemistry, University of Notre Dame, Notre Dame, IN, USA; Harper Cancer Research Institute, University of Notre Dame, South Bend, IN, USA. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 10; Vol. 503, pp. 163-173. Date of Electronic Publication: 2021 Jan 30.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Factors associated with chemotherapy benefit in breast cancer patients with midrange Oncotype DX breast recurrence scores.
Autorzy :
Cheng R; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Wang Z; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Kong X; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
Wang J; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Electronic address: .
Fang Y; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Electronic address: .
Qi L; Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Electronic address: .
Pokaż więcej
Źródło :
Cancer letters [Cancer Lett] 2021 Apr 10; Vol. 503, pp. 213-219. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji :
Journal Article
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies